The WHO released new guidance on GLP-1 medications for adults with obesity, recommending their long-term, continuous use when ...

The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion ...

The weight loss medications can be part of a long-term treatment strategy for adults, according to new World Health ...

WHO issues conditional guidance on GLP‑1 therapies for obesity, calling for wider access amid high prices, safety questions & ...

On World AIDS Day, the World Health Organization (WHO) calls on governments and partners to rapidly expand access to new ...

WHO officially recognizes cannabis hyperemesis syndrome, a dangerous vomiting disorder linked to chronic marijuana use, ...

The World Health Organization on Monday issued its first guideline on the use of GLP-1 therapies for obesity, conditionally ...

The World Health Organization (WHO) today called on countries to make fertility care safer, fairer and more affordable for ...

New WHO guidance calls for a worldwide obesity treatment “ecosystem” to ensure that GLP-1 weight-loss drugs are used fairly ...

Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, ...

The new World Health Organization guideline recognizes obesity as a chronic disease that can be treated with drug therapy as ...

The World Health Organization (WHO) on Monday, Dec. 1, released its first guidelines on the use of Glucagon-Like Peptide-1 ...